NasdaqGM:LNTHMedical Equipment
Lantheus’s 2026 Revenue Guidance Amid Expected Q4 Decline Might Change The Case For Investing In LNTH
Lantheus Holdings recently issued 2026 earnings guidance, projecting revenue between US$1.40 billion and US$1.45 billion, alongside preparations for its upcoming Q4 2025 earnings release.
The combination of fresh full-year revenue guidance and an earnings report expected to show a year-on-year revenue decline has sharpened investor focus on how Lantheus manages its radiopharmaceutical portfolio and pricing pressures.
We’ll now explore how Lantheus’s new 2026 revenue guidance interacts with...